Experiment 575971
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Ginkgo biloba (GINKGOACEAE) |
| Citation | VESPER,J: HANSGEN,KD:. (1994). EFICACY OF GINKGO BILOBA IN 90 OUTPATIENTS WITH CEREBRAL INSUFFICIENCY CAUSED BY OLD AGE. RESULTS OF A PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL.. 1(1) |
| Amount utilized | |
| Compound isolated | |
| Disease | THE EFFICACY OF THE GINKGO BILOBA SPECIAL EXTRACT LI 1370 WAS TESTED IN A DOUBLE-BLIND TRIAL COMPRISING 90 OUTPATIENTS WITH CEREBRAL INSUFFICIENCY. THE AVERAGE AGE OF THE PATIENTS WAS 62.7 YEARS. THE TRIAL WAS CONDUCTED OVER A PEROID OF 12 WEEKS SIGNIFICANT IMPROVEMENTS IN THE PATIENT'S PERFORMANCE WERE OBSERVED UNDER VERUM COMPARED TO THE PLACEBO PREPARATION WHICH WAS ADMINISTERED TO A CONTROL GROUP OF PATIENTS AMONG WHICH THE REVELANT DISORDER WERE DISTRIBUTED HOMOGENEOUSLY THE EFFECTS OF THE PREPARATION WERE RECORDED IN RESPECT OF SPECIFIC PERFORMANCE PARAMETERS AND ARE SUMMARIZED AS FOLLOWS: STABILIZATION OF A MORE CONSISTENT RESPONSE BEHAVIOUR WITH MINOR INTRAINDIVIDUAL VARIATIONS INVOLVED. IMPROVEMENT IN THE PATIENT'S ATTENTION IN RESPECT OF TASKS WHICH REQUIRE QUICK ORIENTATION AND READAPTATION, OR A CONSISTENT ATTENTIVENESS LEVEL TO BE MAINTAINED OVER A LONGER PEROID OF TIME (LONG-TERM STRESS). THE RANGE OF OPTIMUM ATTENTION IN RESPECT OF THE SOLUTION OF TASKS IS ENLARGED AS FAR AS THE TIME IS CONCERNED. IMPROVEMENT OF THE PATIENT'S MEMORY PERFORMANCE PARTICULARLY IN RESPECT OF THE VISUAL MEMORY OF SENSITIVE PARAMETERS OF CEREBRAL INSUFFICIENCY, WHICH MAY ALSO BE DUE TO THE IMPROVEMENT IN CONCENTRATION POWER. POSITIVE CHANGES OF HTE PATIENT'S SUBJECTIVE PERFORMANCE, WHICH ARE EXPERIENCED BY THE PATIENT HIMSELF (REDUCTION OF TROUBLES, REDUCTION OF BEHAVIORAL ABNORMALITIES) AND BY THE PEOPLE IN HIS ENVIRONMENT (OBJECTIVE ASSESSMENT OF BEHAVIOUR). IT WAS SHOWN BY THE STUDY THAT THE TEST PREPARATION SHOULD BE USED OVER A MINIMUM PERIOD OF TIME, SINCE IMPROVEMENTS OF SOME OF THE PARAMETERS WERE NOT OBSERVED UNTIL THE 6TH WEEK OF TREATMENT. THE CLINICAL EFFICACY OF L1 1370 WAS CLEARLY ESTABLISHED. |
| Dose amount | 150.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | ETOH(30%)EXT |
| Gender | GIVEN TO BOTH SEXES |